As to renal carcinoma, patients with low levels of KIAA0101 and EPO had a relative higher 3 and 5-year survival rate (Figure 8G and 8J, KIAA0101: p = 0.0367, EPO: p = 0.0863). Here, PCLAF is linked to renal carcinoma.